NCT05370716View on ClinicalTrials.gov

"Drug-Drug Interaction Study of CG-651 in Healthy Volunteer"

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

May 19, 2020

Conditions
Healthy
Interventions
DRUG

Polmacoxib

Polmacoxib

DRUG

Pregabalin

Pregabalin

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

CrystalGenomics, Inc.

INDUSTRY